Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

UPDATE: Medifast Q2 EPS $0.22 Beats $(0.22) Estimate, Sales $105.600M Beat $96.100M Estimate

Author: Benzinga Newsdesk | August 04, 2025 04:58pm
Medifast (NYSE:MED) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $(0.22) by 200 percent. This is a 76.09 percent decrease over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $105.600 million which beat the analyst consensus estimate of $96.100 million by 9.89 percent. This is a 37.35 percent decrease over sales of $168.558 million the same period last year.

Posted In: MED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist